Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sathyamangalam Swaminathan

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Current Molecular Medicine|March 12, 2009
Dengue: recent advances in biology and current status of translational researchSathyamangalam Swaminathan, Navin Khanna
The New England Journal of Medicine|April 30, 2020
Tetravalent Dengue Vaccine in Healthy ChildrenSathyamangalam Swaminathan, Navin Khanna
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 27, 2019
Dengue vaccine development: Global and Indian scenariosSathyamangalam Swaminathan, Navin Khanna
Virus Research|August 2, 2021
Adenovirus type 5 vectors encoding short hairpin RNAs targeting dengue virus 5' non-translated region and capsid gene suppress pre-established dengue infection in cultured epithelial and myeloid cellsHemalatha Beesetti, Sathyamangalam Swaminathan
Vaccine|July 25, 2006
Induction of neutralizing antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectorsSaima Khanam, Navin Khanna, Sathyamangalam Swaminathan
Expert Opinion on Investigational Drugs|June 21, 2016
Investigational drugs in early development for treating dengue infectionHemalatha Beesetti, Navin Khanna, Sathyamangalam Swaminathan
Expert Opinion on Therapeutic Patents|April 14, 2010
Dengue vaccines: state of the artSathyamangalam Swaminathan, Gaurav Batra, Navin Khanna
Expert Opinion on Therapeutic Patents|February 11, 2010
Adenovirus-vectored vaccinesTanu Chawla, Navin Khanna, Sathyamangalam Swaminathan
Virus Research|July 19, 2005
The identification of immunodominant linear epitopes of dengue type 2 virus capsid and NS4a proteins using pin-bound peptidesRavulapalli Anandarao, Sathyamangalam Swaminathan, Navin Khanna
Protein Expression and Purification|December 19, 2003
High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coliSmita Jaiswal, Navin Khanna, Sathyamangalam Swaminathan
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Current Molecular Medicine|March 12, 2009
Dengue: recent advances in biology and current status of translational researchSathyamangalam Swaminathan, Navin Khanna
The New England Journal of Medicine|April 30, 2020
Tetravalent Dengue Vaccine in Healthy ChildrenSathyamangalam Swaminathan, Navin Khanna
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 27, 2019
Dengue vaccine development: Global and Indian scenariosSathyamangalam Swaminathan, Navin Khanna
Virus Research|August 2, 2021
Adenovirus type 5 vectors encoding short hairpin RNAs targeting dengue virus 5' non-translated region and capsid gene suppress pre-established dengue infection in cultured epithelial and myeloid cellsHemalatha Beesetti, Sathyamangalam Swaminathan
Vaccine|July 25, 2006
Induction of neutralizing antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectorsSaima Khanam, Navin Khanna, Sathyamangalam Swaminathan
Expert Opinion on Investigational Drugs|June 21, 2016
Investigational drugs in early development for treating dengue infectionHemalatha Beesetti, Navin Khanna, Sathyamangalam Swaminathan
Expert Opinion on Therapeutic Patents|April 14, 2010
Dengue vaccines: state of the artSathyamangalam Swaminathan, Gaurav Batra, Navin Khanna
Expert Opinion on Therapeutic Patents|February 11, 2010
Adenovirus-vectored vaccinesTanu Chawla, Navin Khanna, Sathyamangalam Swaminathan
Virus Research|July 19, 2005
The identification of immunodominant linear epitopes of dengue type 2 virus capsid and NS4a proteins using pin-bound peptidesRavulapalli Anandarao, Sathyamangalam Swaminathan, Navin Khanna
Protein Expression and Purification|December 19, 2003
High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coliSmita Jaiswal, Navin Khanna, Sathyamangalam Swaminathan
Pageof 5